HER3: Survival Pathway and Therapeutic Target in Metastatic Colorectal and Pancreatic Cancer
May 24, 2023
PRESS RELEASE: On May 10, 2023, a new research perspective was published in Oncotarget, entitled, “HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.” continue reading »